Vitamin D Deficiency Persists in Summer: Why Sun Exposure Alone May Not Be Sufficient

A widely circulated news report in late July 2025 challenged a foundational assumption in vitamin D physiology: that summer sun exposure reliably corrects deficiency in most populations. The story, citing new research, stated plainly that "summer sunshine alone may not be enough to resolve vitamin D deficiency." For consumers who have been told to simply spend more time outdoors between April and September, the claim raises immediate questions about supplementation timing, dosing, and the actual contribution of dermal synthesis to year-round vitamin D status.

The evidence behind the headline is not new in principle—seasonal variation in 25-hydroxyvitamin D [25(OH)D] concentrations has been documented for decades—but recent population-level data have quantified just how many individuals fail to achieve sufficiency despite geographic and behavioral access to summer UV-B radiation. This brief examines what the research actually shows, which populations remain at risk during peak sunlight months, and what supplementation protocols are supported when dermal synthesis proves insufficient.

What is Vitamin D Deficiency?

Vitamin D deficiency is defined by the concentration of 25-hydroxyvitamin D in serum, the accepted biomarker of whole-body vitamin D status. Clinical guidelines from the Endocrine Society classify deficiency as serum 25(OH)D below 20 ng/mL (50 nmol/L), insufficiency as 21–29 ng/mL, and sufficiency as 30 ng/mL or higher. Other organizations, including the Institute of Medicine, use slightly different thresholds, but the 30 ng/mL cutoff is widely accepted as the minimum for optimal skeletal and extraskeletal function.

Vitamin D is synthesized in the skin when 7-dehydrocholesterol is photolyzed by ultraviolet-B radiation (wavelengths 290–315 nm) to form previtamin D₃, which then isomerizes to cholecalciferol. This endogenous production is highly variable and depends on latitude, season, time of day, skin pigmentation, age, sunscreen use, and body surface area exposed. The cholecalciferol produced in skin—or ingested from food or supplements—is hydroxylated in the liver to 25(OH)D, then converted in the kidneys to the active hormone 1,25-dihydroxyvitamin D, which regulates calcium absorption, bone mineralization, immune modulation, and gene expression across hundreds of cellular pathways.

Because 25(OH)D has a circulating half-life of approximately 15 days, serum concentrations reflect integrated vitamin D input over the preceding weeks, making it the standard clinical marker. Deficiency is associated with increased risk of rickets in children, osteomalacia in adults, elevated parathyroid hormone, accelerated bone loss, and—in observational studies—higher incidence of falls, fractures, respiratory infections, autoimmune conditions, and cardiovascular events. Whether these associations are causal in all cases remains under investigation, but the skeletal consequences of frank deficiency are unequivocal.

What is Summer Vitamin D Deficiency?

Summer vitamin D deficiency refers to the persistence of serum 25(OH)D concentrations below 20 ng/mL—or failure to reach sufficiency above 30 ng/mL—during months when ambient UV-B radiation is theoretically adequate for cutaneous vitamin D synthesis. In temperate latitudes (roughly 30° to 55° N or S), UV-B intensity peaks between April and September in the Northern Hemisphere, when solar elevation angles permit 7-dehydrocholesterol photolysis in skin. Conventional public health messaging has long assumed that regular outdoor exposure during these months would normalize vitamin D status in most individuals, obviating the need for supplementation until autumn.

Population surveys, however, have documented substantial prevalence of insufficiency and deficiency even at the summer nadir of the annual cycle. A 2015 analysis of German adults found that 26% of men and 29% of women had serum 25(OH)D below 20 ng/mL in late summer, and more than half remained below 30 ng/mL. Similar patterns have been reported in the United Kingdom, Ireland, and northern United States, with prevalence inversely correlated with outdoor occupational exposure but present across all demographic strata. The phenomenon is not limited to high latitudes: studies in southern Europe and the Middle East have found persistent insufficiency in summer among women with limited sun exposure due to cultural dress norms, indoor employment, or dermatologic photoprotection.

The term "summer deficiency" is thus descriptive rather than mechanistic—it captures the clinical observation that a significant fraction of the population does not achieve adequate vitamin D status from dermal synthesis alone, even when environmental UV-B is abundant. Seasonal and geographic variation in vitamin D status reflects the interplay of behavioral, physiological, and environmental determinants that extend well beyond calendar month and latitude.

Why Summer Sun Exposure May Not Be Sufficient

The gap between theoretical UV-B availability and actual vitamin D synthesis arises from multiple overlapping factors, many of which are amplified in modern populations:

• Indoor occupational and recreational time: Time-use surveys in the United States and Europe show that adults spend 85–90% of waking hours indoors, where window glass blocks UV-B transmission. Even on weekends, discretionary outdoor time averages less than 60 minutes per day in many cohorts, insufficient to drive substantial dermal synthesis.
• Sunscreen and photoprotection: Broad-spectrum sunscreens with SPF ≥15 reduce previtamin D₃ formation by more than 95% when applied as directed. Dermatologic campaigns to prevent skin cancer have increased sunscreen adherence, particularly in fair-skinned populations at elevated melanoma risk, creating a direct trade-off between photoprotection and vitamin D synthesis.
• Skin pigmentation: Melanin absorbs UV-B photons, attenuating 7-dehydrocholesterol photolysis. Individuals with Fitzpatrick skin types IV–VI require 3–6 times longer sun exposure to produce equivalent cholecalciferol compared to type I–II skin. In northern latitudes, this physiological mismatch means that darker-skinned individuals often cannot achieve sufficiency from ambient sunlight alone, even in summer.
• Age-related decline in cutaneous synthesis: Epidermal 7-dehydrocholesterol concentrations decline with age; individuals over 65 produce approximately 25% of the previtamin D₃ generated by younger adults for the same UV-B dose. This reduction is compounded by decreased outdoor activity and increased use of photoprotective clothing in older populations.
• Adiposity and sequestration: Vitamin D is fat-soluble and distributes into adipose tissue, reducing bioavailability of newly synthesized cholecalciferol. Individuals with obesity require 2–3 times higher intake to achieve equivalent serum 25(OH)D concentrations compared to lean individuals, and the same principle applies to cutaneous synthesis.

Taken together, these factors mean that even populations living at favorable latitudes during summer months may not achieve clinically meaningful dermal vitamin D production without deliberate, sustained, unprotected sun exposure—a behavior increasingly at odds with skin cancer prevention guidelines.